|

TQB2450 Clinical Trials

2 actively recruiting trials

Also known as: Carboplatin, Etoposide

Pipeline

Phase 2: 2

Top Sponsors

  • Shanghai Pulmonary Hospital, Shanghai, China1
  • Jiangxi Provincial Cancer Hospital1

Indications

  • Cancer2
  • Neoplasms, Squamous Cell1
  • Neoplasms by Histologic Type1
  • Gastrointestinal Diseases1
  • Esophageal Diseases1

Other2 trials

Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
Phase 2
PD-L1 Antibody (TQB2450) Plus Chemotherapy for Previously Untreated Limited- Stage Small-cell Lung Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.